Literature DB >> 4579506

The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.

D S Robinson, A Nies, C L Ravaris, K R Lamborn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4579506     DOI: 10.1001/archpsyc.1973.04200030093015

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  15 in total

1.  Monoamine oxidase activity in different density gradient fractions of human platelets.

Authors:  D L Murphy; J L Costa; B Shafer; L Corash
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  Editorial: New look at monoamine oxidase inhibitors.

Authors: 
Journal:  Br Med J       Date:  1976-07-10

Review 3.  Periodic health examination, 1990 update: 2. Early detection of depression and prevention of suicide. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

4.  The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.

Authors:  E C Johnstone
Journal:  Psychopharmacologia       Date:  1976-04-15

5.  Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution.

Authors:  A V Juorio; A J Greenshaw; A A Boulton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

6.  Atypical depressive syndromes in varying definitions.

Authors:  Jules Angst; Alex Gamma; Franco Benazzi; Brett Silverstein; Vladeta Ajdacic-Gross; Dominique Eich; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-07-27       Impact factor: 5.270

7.  Some of the problems and difficulties associated with clinical studies of antidepressant agents.

Authors:  F A Jenner
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

8.  The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.

Authors:  M Sandler; V Glover; A Ashford; A Esmail
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 9.  Atypical depression: a comprehensive review.

Authors:  Chi-Un Pae; Haresh Tharwani; David M Marks; Prakash S Masand; Ashwin A Patkar
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 10.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.